Gujarat Kidney

INR
139.85
8.95 (6.84%)
BSENSE

May 08

BSE+NSE Vol: 17.29 lacs

  • Price Points
  • Score
  • Mojo Parameters
  • Total Return
  • News and Corporate Actions
  • Key factors
  • Shareholding
  • Financials
  • CompanyCV
{
  "main_header": {
    "sid": 10039912,
    "name": "Gujarat Kidney",
    "stock_name": "Gujarat Kidney",
    "full_name": "Gujarat Kidney & Super Speciality Ltd",
    "name_url": "stocks-analysis/gujarat-kidney",
    "exchange": 0,
    "exchangecode": "",
    "primexch": 1,
    "country_id": 34,
    "currency": "INR",
    "cmp": "139.85",
    "chg": 8.95,
    "chgp": "6.84%",
    "dir": 1,
    "prev_price": "130.90",
    "mcapval": "1,053.00 Cr",
    "mcap": "Micro Cap",
    "scripcode": 544666,
    "symbol": "GKSL",
    "ind_name": "Hospital",
    "ind_code": 94,
    "indexname": "India SENSEX",
    "isin": "INE0V0W01025",
    "curr_date": "May 08",
    "curr_time": "",
    "bse_nse_vol": "17.29 lacs",
    "exc_status": "Active",
    "traded_date": "May 08, 2026",
    "traded_date_str": "2026 05 08",
    "score": "",
    "scoreText": "",
    "Live": 0,
    "market_time": 0,
    "is_blur": 1,
    "is_blur_class": "blur-registerF-score-header",
    "is_blur_url": "https://www.marketsmojo.com/mojofeed/register?redirect=/stocks-analysis/gujarat-kidney-10039912-0&utm_source=Spage_Header_Score",
    "mojoone": {
      "ismore": 0
    }
  },
  "news": {
    "results": [
      {
        "title": "When is the next results date for Gujarat Kidney & Super Speciality Ltd?",
        "link": "https://www.marketsmojo.com/news/result-analysis/when-is-the-next-results-date-for-gujarat-kidney-super-speciality-ltd-3836104",
        "imagepath": "",
        "date": "2026-02-12 23:16:48",
        "description": "The next results date for Gujarat Kidney & Super Speciality Ltd is scheduled for 14 February 2026...."
      },
      {
        "title": "When is the next results date for Gujarat Kidney & Super Speciality Ltd?",
        "link": "https://www.marketsmojo.com/news/result-analysis/when-is-the-next-results-date-for-gujarat-kidney-super-speciality-ltd-3833825",
        "imagepath": "",
        "date": "2026-02-11 23:17:36",
        "description": "The next results date for Gujarat Kidney & Super Speciality Ltd is scheduled for 13 February 2026...."
      }
    ],
    "total": 2,
    "sid": "10039912",
    "stock_news_url": "https://www.marketsmojo.com/news/gujarat-kidney-super-speciality-10039912"
  },
  "announcements": [
    {
      "caption": "Format of the Initial Disclosure to be made by an entity identified as a Large Corporate : Annexure A",
      "datetime": "30-Apr-2026",
      "details": "<b>Format of Initial Disclosure to be made by an entity identified as a Large Corporate.</b><br/><br/> <table border=1px><tr> <td><b>Sr. No.</b></td> <td><b>Particulars</b></td> <td><b>Details</b></td> </tr> <tr><td>1</td><td>Name of Company</td><td>Gujarat Kidney and Super Speciality Ltd</td></tr> <tr><td>2</td><td>CIN NO.</td><td>U85300GJ2019PLC111559</td></tr> <tr><td>3</td> <td>Outstanding borrowing of company as on 31st March / 31st December as applicable (in Rs cr)</td> <td>1.23</td></tr> <tr><td>4</td><td>Highest Credit Rating during the previous FY </td><td>0</td></tr> <tr><td>4a</td><td>Name of the Credit Rating Agency issuing the Credit Rating mentioned in (4)</td><td>Not Applicable</td></tr> <tr><td>5</td><td>Name of Stock Exchange# in which the fine shall be paid in case of shortfall in the required borrowing under the framework</td><td>BSE</td></tr> </table> <br/><br/> <div> <div style=float:left;> We confirm that we are a Large Corporate as per the applicability criteria given under the SEBI circular SEBI/HO/DDHS/CIR/P/2018/144 dated November 26 2018. No</div> <br/><br/><br/> <div style=float:left;> Name of the Company Secretary: Vishakha Mahesh Phadke <br/> Designation: Company Secretary and Compliance Officer <br/> EmailId: cs@gujaratsuperspecialityhospital.com</div> <div style=float:left;margin-left:50px;> Name of the Chief Financial Officer: Bhavika Mitesh Patel <br/> Designation: Chief Financial Officer <br/> EmailId: cfo@gujaratsuperspecialityhospital.com</div> </div> <div> <br/> Date: 30/04/2026<br/><br/> <b>Note:<b> In terms para of 3.2(ii) of the circular beginning F.Y 2022 in the event of shortfall in the mandatory borrowing through debt securities a fine of 0.2% of the shortfall shall be levied by Stock Exchanges at the end of the two-year block period. Therefore an entity identified as LC shall provide in its initial disclosure for a financial year the name of Stock Exchange to which it would pay the fine in case of shortfall in the mandatory borrowing through debt markets. </div>",
      "source": "BSE"
    },
    {
      "caption": "Announcement under Regulation 30 (LODR)-Acquisition",
      "datetime": "27-Apr-2026",
      "details": "Approval of Incorporation of Wholly Owned Subsidiary (WOS)",
      "source": "BSE"
    },
    {
      "caption": "Appointment of Company Secretary and Compliance Officer",
      "datetime": "27-Apr-2026",
      "details": "Appointment of Mrs Vishakha Mahesh Phadke as Company Secretary and Compliance Officer",
      "source": "BSE"
    }
  ],
  "corporate_actions": [
    {
      "img": "board-meeting.svg",
      "title": "BOARD MEETING",
      "msg": "<span>No</span> Upcoming Board Meetings",
      "data": []
    },
    {
      "img": "dividend.svg",
      "title": "DIVIDEND",
      "msg": "No <strong>Dividend</strong> history available",
      "data": []
    },
    {
      "img": "splits.svg",
      "title": "SPLITS",
      "msg": "No <strong>Splits</strong> history available",
      "data": []
    },
    {
      "img": "bonus.svg",
      "title": "BONUS",
      "msg": "No <strong>Bonus</strong> history available",
      "data": []
    },
    {
      "img": "rights-issues.svg",
      "title": "RIGHTS",
      "msg": "No <strong>Rights</strong> history available",
      "data": []
    }
  ]
}
stock-recommendationAnnouncement

Format of the Initial Disclosure to be made by an entity identified as a Large Corporate : Annexure A

30-Apr-2026 | Source : BSE

Format of Initial Disclosure to be made by an entity identified as a Large Corporate.

Sr. No. Particulars Details
1Name of CompanyGujarat Kidney and Super Speciality Ltd
2CIN NO.U85300GJ2019PLC111559
3 Outstanding borrowing of company as on 31st March / 31st December as applicable (in Rs cr) 1.23
4Highest Credit Rating during the previous FY 0
4aName of the Credit Rating Agency issuing the Credit Rating mentioned in (4)Not Applicable
5Name of Stock Exchange# in which the fine shall be paid in case of shortfall in the required borrowing under the frameworkBSE


We confirm that we are a Large Corporate as per the applicability criteria given under the SEBI circular SEBI/HO/DDHS/CIR/P/2018/144 dated November 26 2018. No



Name of the Company Secretary: Vishakha Mahesh Phadke
Designation: Company Secretary and Compliance Officer
EmailId: cs@gujaratsuperspecialityhospital.com
Name of the Chief Financial Officer: Bhavika Mitesh Patel
Designation: Chief Financial Officer
EmailId: cfo@gujaratsuperspecialityhospital.com

Date: 30/04/2026

Note: In terms para of 3.2(ii) of the circular beginning F.Y 2022 in the event of shortfall in the mandatory borrowing through debt securities a fine of 0.2% of the shortfall shall be levied by Stock Exchanges at the end of the two-year block period. Therefore an entity identified as LC shall provide in its initial disclosure for a financial year the name of Stock Exchange to which it would pay the fine in case of shortfall in the mandatory borrowing through debt markets.

Announcement under Regulation 30 (LODR)-Acquisition

27-Apr-2026 | Source : BSE

Approval of Incorporation of Wholly Owned Subsidiary (WOS)

Appointment of Company Secretary and Compliance Officer

27-Apr-2026 | Source : BSE

Appointment of Mrs Vishakha Mahesh Phadke as Company Secretary and Compliance Officer

stock-recommendationCorporate Actions
Corporate Actions
info
stock-summary
BOARD MEETING

No Upcoming Board Meetings

stock-summary
DIVIDEND

No Dividend history available

stock-summary
SPLITS

No Splits history available

stock-summary
BONUS

No Bonus history available

stock-summary
RIGHTS

No Rights history available